{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T15:48:31Z","timestamp":1791388111174,"version":"4.3.3"},"reference-count":70,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":["neurology.org"],"crossmark-restriction":true},"short-container-title":["Neurology"],"published-print":{"date-parts":[[1995,8]]},"DOI":"10.1212\/wnl.45.8.1570","type":"journal-article","created":{"date-parts":[[2012,5,13]],"date-time":"2012-05-13T13:17:07Z","timestamp":1336915027000},"page":"1570-1577","update-policy":"https:\/\/doi.org\/10.1212\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":109,"title":["Diagnostic value of GM\n            <sub>1<\/sub>\n            antibodies in motor neuron disorders and neuropathies"],"prefix":"10.1212","volume":"45","author":[{"given":"I.N.","family":"van Schaik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.M.M.","family":"Bossuyt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Brand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Vermeulen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_1_2_2","first-page":"4","volume":"36","year":"1986","unstructured":"Freddo L, Yu RK, Latov N, et al. Gangliosides GM1 and GD1b are antigens for IgM M-protein in a patient with motor neuron disease. Neurology 1986;36:454-458.","journal-title":"Neurology"},{"key":"e_1_3_1_3_2","first-page":"2","volume":"19","year":"1988","unstructured":"Ito H, Latov N. Monoclonal IgM in two patients with motor neuron disease bind to the carbohydrate antigens Gal(beta 1-3)GalNac and Gal(beta 1-3)GlcNAc. J Neuroimmunol 1988;19:245-253.","journal-title":"J Neuroimmunol"},{"key":"e_1_3_1_4_2","first-page":"7","volume":"38","year":"1988","unstructured":"Latov N, Hays AP, Donofrio PD, et al. Monoclonal IgM with unique specificity to gangliosides GM1 and GD1b and to lacto-N-tetraose associated with human motor neuron disease. Neurology 1988;38:763-768.","journal-title":"Neurology"},{"key":"e_1_3_1_5_2","first-page":"5","volume":"23","year":"1988","unstructured":"Nardelli E, Steck AJ, Barkas T, Schluep M, Jerusalem F. Motor neuron syndrome and monoclonal IgM with antibody activity against gangliosides GM1 and GD1b. Ann Neurol 1988;23:524-528.","journal-title":"Ann Neurol"},{"key":"e_1_3_1_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/0165-5728(89)90153-7"},{"key":"e_1_3_1_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/0165-5728(89)90065-9"},{"key":"e_1_3_1_8_2","first-page":"1","volume":"80","year":"1990","unstructured":"Jauberteau MO, Gualde N, Preud'homme JL, et al. Human monoclonal IgM with autoantibody activity against two gangliosides (GM1 and GD1b) in a patient with motor neuron syndrome. Clin Exp Immunol 1990;80:186-191.","journal-title":"Clin Exp Immunol"},{"key":"e_1_3_1_9_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410280102"},{"key":"e_1_3_1_10_2","first-page":"8","volume":"49","year":"1990","unstructured":"Thomas FP, Thomas MAJE, Sadiq SA, et al. Human monoclonal IgM anti-Gal(beta 1-3)GalNac autoantibodies bind to the surface of bovine spinal motoneurons. J Neuropathol Exp Neurol 1990;49:89-95.","journal-title":"J Neuropathol Exp Neurol"},{"key":"e_1_3_1_11_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.40.1.1"},{"key":"e_1_3_1_12_2","first-page":"2","volume":"32","year":"1992","unstructured":"Yoshino H, Inuzuka T, Miyatake T. IgG antibody against GM1, GD1b and asialo-GM1 in chronic polyneuropathy following mycoplasma pneumonia infection. Eur Neurol 1992;32:28-31.","journal-title":"Eur Neurol"},{"key":"e_1_3_1_13_2","first-page":"6","volume":"102","year":"1991","unstructured":"Ilyas AA, Mithen FA, Chen Z, Cook SD. Search for antibodies to neutral glycolipids in sera of patients with Guillain-Barre syndrome. J Neurol Sci 1991;102:67-75.","journal-title":"J Neurol Sci"},{"key":"e_1_3_1_14_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.55.Suppl.8"},{"key":"e_1_3_1_15_2","first-page":"2","volume":"109","year":"1992","unstructured":"Nobile-Orazio E, Carpo M, Meucci N, et al. Guillain-Barre syndrome associated with high titers of anti-GM1 antibodies. J Neurol Sci 1992;109:200-206.","journal-title":"J Neurol Sci"},{"key":"e_1_3_1_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/0022-510X(92)90202-V"},{"key":"e_1_3_1_17_2","first-page":"6","volume":"36","year":"1992","unstructured":"Ilyas AA, Mithen FA, Chen Z, Cook SD. Anti-GM1 IgA antibodies in Guillain-Barre syndrome. J Neuroimmunol 1992;36:69-76.","journal-title":"J Neuroimmunol"},{"key":"e_1_3_1_18_2","doi-asserted-by":"publisher","DOI":"10.1002\/mus.880140102"},{"key":"e_1_3_1_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/0022-510X(80)90039-8"},{"key":"e_1_3_1_20_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.132.1.1"},{"key":"e_1_3_1_21_2","first-page":"5","volume":"27","year":"1990","unstructured":"Salazar-Grueso EF, Routbort MJ, Martin J, Dawson G, Roos RP. Polyclonal IgM anti-GM1 ganglioside antibody in patients with motor neuron disease and variants. Ann Neurol 1990;27:558-563.","journal-title":"Ann Neurol"},{"key":"e_1_3_1_22_2","first-page":"7","volume":"24","year":"1988","unstructured":"Pestronk A, Cornblath DR, Ilyas AA, et al. A treatable multifocal motor neuropathy with antibodies to GM1 ganglioside. Ann Neurol 1988;24:73-78.","journal-title":"Ann Neurol"},{"key":"e_1_3_1_23_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410270103"},{"key":"e_1_3_1_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/0165-5728(89)90081-7"},{"key":"e_1_3_1_25_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.40.1.8"},{"key":"e_1_3_1_26_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410230103"},{"key":"e_1_3_1_27_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410300103"},{"key":"e_1_3_1_28_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.42.1.5"},{"key":"e_1_3_1_29_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410280103"},{"key":"e_1_3_1_30_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410310103"},{"key":"e_1_3_1_31_2","first-page":"5","volume":"16","year":"1993","unstructured":"Arasaki K, Kusunoki S, Kudo N, Kanazawa I. Acute conduction block in vitro following exposure to antiganglioside sera. Muscle Nerve 1993;16:587-593.","journal-title":"Muscle Nerve"},{"key":"e_1_3_1_32_2","first-page":"4","volume":"32","year":"1992","unstructured":"Corbo M, Quattrini A, Lugaresi A, Santoro M, Latov N, Hays AP. Patterns of reactivity of human anti-GM1 antibodies with spinal cord and motor neurons. Ann Neurol 1992;32:487-493.","journal-title":"Ann Neurol"},{"key":"e_1_3_1_33_2","first-page":"7","volume":"16","year":"1993","unstructured":"Kusunoki S, Chiba A, Tai T, Kanazawa I. Localization of GM1 and GD1b antigens in the human peripheral nervous system. Muscle Nerve 1993;16:752-756.","journal-title":"Muscle Nerve"},{"key":"e_1_3_1_34_2","first-page":"9","volume":"17","year":"1994","unstructured":"Parry GJ. Antiganglioside antibodies do not necessarily play a role in multifocal motor neuropathy. Muscle Nerve 1994;17:97-99.","journal-title":"Muscle Nerve"},{"key":"e_1_3_1_35_2","first-page":"1","volume":"17","year":"1994","unstructured":"Lange DJ, Trojaborg W. Do GM1 antibodies induce demyelination? Muscle Nerve 1994;17:105-107.","journal-title":"Do GM1 antibodies induce demyelination? Muscle Nerve"},{"key":"e_1_3_1_36_2","doi-asserted-by":"publisher","DOI":"10.1002\/mus.880170102"},{"key":"e_1_3_1_37_2","unstructured":"Cooper H Hedges LV. The handbook of research synthesis. New York: Russell Sage Foundation 1994."},{"key":"e_1_3_1_38_2","first-page":"5","volume":"40","year":"1990","unstructured":"Younger DS, Rowland LP, Latov N, et al. Motor neuron disease and amyotrophic lateral sclerosis: relation of high CSF protein content to paraproteinemia and clinical syndromes. Neurology 1990;40:595-599.","journal-title":"Neurology"},{"key":"e_1_3_1_39_2","doi-asserted-by":"crossref","unstructured":"Parry GJ Sumner AJ. Multifocal motor neuropathy. In: Dyck PJ Thomas PK Griffin JW eds. Neurologic clinics. Peripheral neuropathy: new concepts and treatments. Philadelphia: WB Saunders 1992:671-684.","DOI":"10.1016\/S0733-8619(18)30203-2"},{"key":"e_1_3_1_40_2","first-page":"6","volume":"41","year":"1991","unstructured":"Ad hoc subcommittee of the American Academy of Neurology AIDS Task Force. Research criteria for diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP). Neurology 1991;41:617-618.","journal-title":"Neurology"},{"key":"e_1_3_1_41_2","first-page":"2","volume":"48","year":"1991","unstructured":"Van Doorn PA, Vermeulen M, Brand A, Mulder PGH, Busch HFM. Intravenous immunoglobulin treatment in patients with chronic inflammatory demyelinating polyneuropathy. Arch Neurol 1991;48:217-220.","journal-title":"Arch Neurol"},{"key":"e_1_3_1_42_2","doi-asserted-by":"crossref","unstructured":"Asbury AK Cornblath DR. Assessment of current diagnostic criteria for Guillain-Barre syndrome. Ann Neurol 1990;27(suppl):S21-S24.","DOI":"10.1002\/ana.410270707"},{"key":"e_1_3_1_43_2","first-page":"5","volume":"94","year":"1981","unstructured":"Griner PF, Mayewski RJ, Mushlin AI, Greenland P. Selection and interpretation of diagnostic tests and procedures: principles and applications. Ann Intern Med 1981;94:553-600.","journal-title":"Ann Intern Med"},{"key":"e_1_3_1_44_2","first-page":"9","volume":"25","year":"1989","unstructured":"Pestronk A, Adams RN, Cornblath DR, Kuncl RW, Drachman DB, Clawson L. Patterns of serum IgM antibodies to GM1 and GD1a gangliosides in amyotrophic lateral sclerosis. Ann Neurol 1989;25:98-102.","journal-title":"Ann Neurol"},{"key":"e_1_3_1_45_2","first-page":"5","volume":"25","year":"1989","unstructured":"Shy ME, Evans VA, Lublin FD, et al. Antibodies to GM1 and GD (1b) in patients with motor neuron disease without plasma cell dyscrasia. Ann Neurol 1989;25:511-513.","journal-title":"Ann Neurol"},{"key":"e_1_3_1_46_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.40.1.1"},{"key":"e_1_3_1_47_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.38.1.1"},{"key":"e_1_3_1_48_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.40.1.1"},{"key":"e_1_3_1_49_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.41.1.1"},{"key":"e_1_3_1_50_2","first-page":"4","volume":"42","year":"1992","unstructured":"Lange DJ, Trojaborg W, Latov N, et al. Multifocal motor neuropathy with conduction block: is it a distinct clinical entity? Neurology 1992;42:497-505.","journal-title":"Multifocal motor neuropathy with conduction block: is it a distinct clinical entity? Neurology"},{"key":"e_1_3_1_51_2","first-page":"1","volume":"86","year":"1993","unstructured":"Gregson NA, Koblar S, Hughes RAC. Antibodies to gangliosides in Guillain-Barre syndrome: specificity and relationship to clinical features. Q J Med 1993;86:111-117.","journal-title":"Q J Med"},{"key":"e_1_3_1_52_2","first-page":"2","volume":"32","year":"1991","unstructured":"Adams D, Kuntzer T, Burger D, et al. Predictive value of anti-GM (1) ganglioside antibodies in neuromuscular diseases: a study of 180 sera. J Neuroimmunol 1991;32:223-230.","journal-title":"J Neuroimmunol"},{"key":"e_1_3_1_53_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.56.1.2"},{"key":"e_1_3_1_54_2","first-page":"4","volume":"43","year":"1993","unstructured":"Sanders KA, Rowland LP, Murphy PL, et al. Motor neuron diseases and amyotrophic lateral sclerosis: GM1 antibodies and paraproteinemia. Neurology 1993;43:418-420.","journal-title":"Neurology"},{"key":"e_1_3_1_55_2","first-page":"8","volume":"15","year":"1992","unstructured":"Yuki N, Yoshino H, Sato S, Shinozawa K, Miyatake T. Severe acute axonal form of Guillain-Barre syndrome associated with IgG anti-GD1a antibodies. Muscle Nerve 1992;15:899-903.","journal-title":"Muscle Nerve"},{"key":"e_1_3_1_56_2","first-page":"5","volume":"86","year":"1992","unstructured":"Voumvourakis C, Rombos A, Konstantoulakis MM, Segditsa I, Papageorgiou C. Serum anti-GM1 and anti-GD1a antibodies in patients with motor neuron disease. Acta Neurol Scand 1992;86:599-602.","journal-title":"Acta Neurol Scand"},{"key":"e_1_3_1_57_2","first-page":"4","volume":"86","year":"1992","unstructured":"Stevens A, Weller SA, Wietholter H. CSF and serum ganglioside antibody patterns in MS. Acta Neurol Scand 1992;86:485-489.","journal-title":"Acta Neurol Scand"},{"key":"e_1_3_1_58_2","first-page":"4","volume":"34","year":"1991","unstructured":"Walsh FS, Cronin M, Koblar S, et al. Association between glycoconjugate antibodies and Campylobacter infection in patients with Guillain-Barre syndrome. J Neuroimmunol 1991;34:43-51.","journal-title":"J Neuroimmunol"},{"key":"e_1_3_1_59_2","first-page":"2","volume":"112","year":"1992","unstructured":"Mithen FA, Ilyas AA, Birchem R, Cook SD. Effects of Guillain-Barre sera containing antibodies against glycolipids in cultures of Schwann cells and sensory neurons. J Neurol Sci 1992;112:223-232.","journal-title":"J Neurol Sci"},{"key":"e_1_3_1_60_2","first-page":"4","volume":"239","year":"1992","unstructured":"Weller M, Stevens A, Sommer N, Dichgans J, Kappler B, Wietholter H. Ganglioside antibodies: a lack of diagnostic specificity and clinical utility? J Neurol 1992;239:455-459.","journal-title":"Ganglioside antibodies: a lack of diagnostic specificity and clinical utility? J Neurol"},{"key":"e_1_3_1_61_2","first-page":"3","volume":"56","year":"1993","unstructured":"Stevens A, Weller M, Wietholter H. A characteristic ganglioside antibody pattern in the CSF of patients with amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 1993;56:361-364.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"e_1_3_1_62_2","first-page":"2","volume":"114","year":"1993","unstructured":"Willison HJ, Chancellor AM, Paterson G, et al. Antiglycolipid antibodies, immunoglobulins and paraproteins in motor neuron disease: a population based case-control study. J Neurol Sci 1993;114:209-215.","journal-title":"J Neurol Sci"},{"key":"e_1_3_1_63_2","first-page":"4","volume":"114","year":"1993","unstructured":"Simone IL, Annunziata P, Maimone D, Liguori M, Leante R, Livrea P. Serum and CSF anti-GM1 antibodies in patients with Guillain-Barre syndrome and chronic inflammatory demyelinating polyneuropathy. J Neurol Sci 1993;114:49-55.","journal-title":"J Neurol Sci"},{"key":"e_1_3_1_64_2","doi-asserted-by":"publisher","DOI":"10.1002\/mus.880160103"},{"key":"e_1_3_1_65_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410230705"},{"key":"e_1_3_1_66_2","first-page":"3","volume":"20","year":"1992","unstructured":"Ben Younes-Chennoufi A, Meininger V, Leger JM, Bouche P, Jauberteau MO, Baumann N. Antiganglioside antibodies in motor neuron disease and peripheral neuropathies: study by ELISA technique and immunodetection on thin-layer chromatography. Neurochem Int 1992;20:353-357.","journal-title":"Neurochem Int"},{"key":"e_1_3_1_67_2","first-page":"1","volume":"242","year":"1992","unstructured":"Weller M, Stevens A, Sommer N, Wietholter H. Are CSF or serum ganglioside antibodies related to peripheral nerve demyelination in neuroborreliosis, Guillain-Barre syndrome, or chronic inflammatory demyelinating polyradiculoneuropathy? Eur Arch Psychiatry Clin Neurosci 1992;242:122-126.","journal-title":"Are CSF or serum ganglioside antibodies related to peripheral nerve demyelination in neuroborreliosis, Guillain-Barre syndrome, or chronic inflammatory demyelinating polyradiculoneuropathy? Eur Arch Psychiatry Clin Neurosci"},{"key":"e_1_3_1_68_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199201023260101"},{"key":"e_1_3_1_69_2","first-page":"2","volume":"33","year":"1993","unstructured":"Chaudhry V, Corse AM, Cornblath DR, et al. Multifocal motor neuropathy: response to human immune globulin. Ann Neurol 1993;33:237-242.","journal-title":"Ann Neurol"},{"key":"e_1_3_1_70_2","first-page":"5","volume":"43","year":"1993","unstructured":"Nobile-Orazio E, Meucci N, Barbieri S, Carpo M, Scarlato G. High-dose intravenous immunoglobulin therapy in multifocal motor neuropathy. Neurology 1993;43:537-544.","journal-title":"Neurology"},{"key":"e_1_3_1_71_2","first-page":"2","volume":"25","year":"1989","unstructured":"Marcus DM, Latov N, hsi BP, Gillard BK, and participating laboratories. Measurement and significance of antibodies against GM1 ganglioside. Report of a workshop. J Neuroimmunol 1989;25:255-259.","journal-title":"J Neuroimmunol"}],"container-title":["Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.neurology.org\/doi\/pdfdirect\/10.1212\/WNL.45.8.1570","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,28]],"date-time":"2024-03-28T16:14:31Z","timestamp":1711642471000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.neurology.org\/doi\/10.1212\/WNL.45.8.1570"}},"subtitle":["A meta-analysis"],"short-title":[],"issued":{"date-parts":[[1995,8]]},"references-count":70,"journal-issue":{"issue":"8","published-print":{"date-parts":[[1995,8]]}},"alternative-id":["10.1212\/WNL.45.8.1570"],"URL":"https:\/\/doi.org\/10.1212\/wnl.45.8.1570","relation":{},"ISSN":["0028-3878","1526-632X"],"issn-type":[{"value":"0028-3878","type":"print"},{"value":"1526-632X","type":"electronic"}],"subject":[],"published":{"date-parts":[[1995,8]]}}}